CRBP   $17.42  4.12% Market Closed After Close 17.0153 -2.32%

Corbus Pharmaceuticals Holdings Inc

EMA (20): 2024-11-06 the price crossed down the moving average line and demonstrates a downside trend.

EMA (50): 2024-09-17 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (100): 2024-09-20 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's higher than the signal line and grows. These factors mean that the falling period is over. Last signal: exit from the oversold zone.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and left the oversold territory. These factors indicate that perhaps the downside trend is coming to an end price will probably head north Last signal: exit from the oversold zone.

Trend Type turning down
Power medium strength
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -11.67%
EMA (20) date of signal Nov. 6, 2024, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -67.18%
EMA (50) date of signal Sept. 17, 2024, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -14.25%
EMA (100) date of signal Sept. 20, 2024, 3 a.m.
RSI Signals bearish weakening
RSI (14) Yield 0.0
RSI (14) date of signal Nov. 21, 2024, 3 a.m.
MACD Signals bullish reversal
MACD Yield -12.09%
MACD date of signal Oct. 7, 2024, 3 a.m.
Stochastic Signals bullish reversal
Stochastic Yield 0.0
Stochastic date of signal Nov. 21, 2024, 3 a.m.
Updated Nov. 22, 2024, 11:01 p.m.